Table 2 ERCP characteristics and complications.

From: IL-6, IL-10 and TNFα do not improve early detection of post-endoscopic retrograde cholangiopancreatography acute pancreatitis: a prospective cohort study

 

Total

PEP*

No PEP

P value

(n = 510)

(n = 36)

(n = 474)

Cholangiography

481 (94.3%)

36 (100%)

445 (93.9%)

0.25

Biliary duct diameter (mm; mean ± SD)

11 ± 4

11 ± 5

11 ± 4

0.45

Wirsung opacification

133 (26.1%)

12 (33.3%)

121 (25.5%)

0.3

Pancreatic acinarization

12 (2.4%)

2 (5.6%)

10 (2.1%)

0.21

Contrast injection (ml)

14 ± 8

13 ± 7

14 ± 8

0.92

>3 pancreatic duct injections

39 (7.6%)

4 (11.1%)

35 (7.4%)

0.34

Biliary sphincterotomy

465 (91.2%)

35 (97.2%)

430 (90.7%)

0.35

Biliary stent

152 (29.8%)

12 (33.3%)

140 (29.5%)

0.71

Precut sphincterotomy

78 (15.3%)

5 (13.9%)

73 (15.4%)

0.81

Cannulation difficulty

 1–5 attempts

310 (60.8%)

18 (50%)

292 (61.6%)

0.33

 6–15 attempts

111 (21.8%)

11 (30.6%)

100 (21.1%)

 >15 attempts

89 (17.4%)

7 (19.4%)

82 (17.3%)

Cannulation failure at first endoscopy

33 (6.5%)

1 (2.8%)

32 (6.8%)

0.5

Intradiverticular papilla

86 (16.9%)

3 (8.3%)

83 (17.5%)

0.25

Procedure time (minutes)

30 ± 21

31 ± 17

30 ± 21

0.94

Complications

 Acute pancreatitis

36 (7.1%)

   

  -Severe

2 (5.6%)

   

  -Moderate

13 (36.1%)

   

  -Mild

21 (58.3%)

   

 Bleeding

21 (4.1%)

   

 Cholangitis

12 (2.4%)

   

 Perforation

3 (0.6%)

   

 Deceased

1 (0.2%)

   
  1. *PEP: post-ERCP pancreatitis.